BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 15459904)

  • 1. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
    Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
    Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: metabolic analysis.
    Dalm MC; Lamers PP; Cuijten SM; Tjeerdsma AM; van Grunsven WM; Tramper J; Martens DE
    Biotechnol Prog; 2007; 23(3):560-9. PubMed ID: 17439155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model simulation and analysis of perfusion culture of mammalian cells at high cell density.
    Zeng AP; Deckwer WD
    Biotechnol Prog; 1999; 15(3):373-82. PubMed ID: 10356254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial and total cell retention in a filtration-based homogeneous perfusion reactor.
    Banik GG; Heath CA
    Biotechnol Prog; 1995; 11(5):584-8. PubMed ID: 8546841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable hybridoma cultivation in a pilot-scale acoustic perfusion system: long-term process performance and effect of recirculation rate.
    Dalm MC; Jansen M; Keijzer TM; van Grunsven WM; Oudshoorn A; Tramper J; Martens DE
    Biotechnol Bioeng; 2005 Sep; 91(7):894-900. PubMed ID: 15959892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On-line monitoring of oxygen uptake rate and its application in hybridoma culture].
    Feng Q; Mi L; Li L; Wang XH; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):593-7. PubMed ID: 15969090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms.
    Gramer MJ; Britton TL
    Biotechnol Bioeng; 2002 Aug; 79(3):277-83. PubMed ID: 12115416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
    Cherlet M; Marc A
    Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
    Tey BT; Al-Rubeai M
    Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.
    Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J
    Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and rate laws of growth and death of hybridoma cells in continuous culture.
    Zeng AP; Deckwer WD; Hu WS
    Biotechnol Bioeng; 1998 Mar; 57(6):642-54. PubMed ID: 10099244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of three-dimensional culturing in a fibrous matrix on cell cycle, apoptosis, and MAb production by hybridoma cells.
    Luo J; Yang ST
    Biotechnol Prog; 2004; 20(1):306-15. PubMed ID: 14763857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive control of hollow-fiber bioreactors for the production of monoclonal antibodies.
    Dowd JE; Weber I; Rodriguez B; Piret JM; Kwok KE
    Biotechnol Bioeng; 1999 May; 63(4):484-92. PubMed ID: 10099629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the chemical composition of cell culture material on the growth and antibody production of hybridoma cells.
    Heilmann K; Groth T; Behrsing O; Albrecht W; Schossig M; Lendlein A; Micheel B
    J Biotechnol; 2005 Feb; 115(3):291-301. PubMed ID: 15639091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous conditions in dissolved oxygen affect N-glycosylation but not productivity of a monoclonal antibody in hybridoma cultures.
    Serrato JA; Palomares LA; Meneses-Acosta A; Ramírez OT
    Biotechnol Bioeng; 2004 Oct; 88(2):176-88. PubMed ID: 15449295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic optimization of hybridoma growth in a fed-batch bioreactor.
    Dhir S; Morrow KJ; Rhinehart RR; Wiesner T
    Biotechnol Bioeng; 2000 Jan; 67(2):197-205. PubMed ID: 10592517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.